Literature DB >> 9316544

Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents.

J Schwitter1, M Saeed, M F Wendland, N Derugin, E Canet, R C Brasch, C B Higgins.   

Abstract

OBJECTIVES: This study sought to 1) compare the distribution of extravascular (573 Da) and intravascular (92 kDa) magnetic resonance (MR) contrast agents in reperfused infarcted myocardium, and 2) investigate the effect of injury severity on these distribution patterns.
BACKGROUND: Myocardial distribution of low and high molecular weight contrast agents depends on vascular permeability, diffusive/convective transport within the interstitium and accessibility of the intracellular compartment (cellular integrity).
METHODS: To vary the severity of myocardial injury, 72 rats were subjected to 20, 30, 45 or 75 min (n = 18, respectively) of coronary artery occlusion. After 2 h of reflow, the animals received either 0.05 mmol/kg of gadolinium-diethylenetriaminepentaacetic acid-bismethylamide (Gd-DTPA-BMA) (n = 24), (Gd-DTPA)30-albumin (n = 24) or saline (control group, n = 24). Three minutes after injection, the hearts were excised and imaged (spin-echo imaging parameters: repetition time 300 ms, echo time 8 ms, 2-tesla system), followed by triphenyltetrazolium chloride staining for infarct detection and sizing.
RESULTS: Histomorphometric and MR infarct size (expressed as percent of slice surface) correlated well: r = 0.96 for Gd-DTPA-BMA; r = 0.95 for (Gd-DTPA)30-albumin. On Gd-DTPA-BMA-enhanced images, reperfused myocardial infarctions were homogeneously enhanced. The ratio of signal intensity of infarcted/ normal myocardium increased with increasing duration of ischemia (overall p < 0.0001, analysis of variance [ANOVA]), indicating an increase in the distribution volume of Gd-DTPA-BMA in postischemic myocardium. On (Gd-DTPA)30-albumin-enhanced images, reperfused infarctions consisted of a bright border zone and a less enhanced central core. The extent of the core increased with increasing duration of ischemia (overall p value < 0.0001, ANOVA).
CONCLUSIONS: At 2 h of reperfusion, the distribution of MR contrast agents in postischemic myocardium is 1) specific for extravascular and intravascular agents, and 2) modulated by the duration of ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316544     DOI: 10.1016/s0735-1097(97)00245-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group.

Authors:  M Jerosch-Herold; N Wilke; Y Wang; G R Gong; A M Mansoor; H Huang; S Gurchumelidze; A E Stillman
Journal:  Int J Card Imaging       Date:  1999-12

Review 2.  Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside.

Authors:  Pierre Croisille; Didier Revel; Maythem Saeed
Journal:  Eur Radiol       Date:  2006-04-22       Impact factor: 5.315

3.  Optimization of myocardial nulling in pediatric cardiac MRI.

Authors:  Edythe B Tham; Ryan W Hung; Kimberley A Myers; Cinzia Crawley; Michelle L Noga
Journal:  Pediatr Radiol       Date:  2011-10-18

Review 4.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

5.  Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique.

Authors:  Amardeep Ghosh Dastidar; Iwan Harries; Giulia Pontecorboli; Vito D Bruno; Estefania De Garate; Charlie Moret; Anna Baritussio; Thomas W Johnson; Elisa McAlindon; Chiara Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-24       Impact factor: 2.357

6.  Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.

Authors:  Michael J Lipinski; M Teresa Albelda; Juan C Frias; Stasia A Anderson; Dror Luger; Peter C Westman; Ricardo O Escarcega; David G Hellinga; Ron Waksman; Andrew E Arai; Stephen E Epstein
Journal:  Cardiovasc Revasc Med       Date:  2016-01-21

7.  Acute infarct selective MRI contrast agent.

Authors:  Robert Kirschner; Akos Varga-Szemes; Tamas Simor; Pal Suranyi; Pal Kiss; Balazs Ruzsics; Brigitta C Brott; Ada Elgavish; Gabriel A Elgavish
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-19       Impact factor: 2.357

8.  Quantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in mice.

Authors:  Eissa N E Aguor; Fatih Arslan; Cees W A van de Kolk; Marcel G J Nederhoff; Pieter A Doevendans; Cees J A van Echteld; Gerard Pasterkamp; Gustav J Strijkers
Journal:  MAGMA       Date:  2012-02-11       Impact factor: 2.310

Review 9.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

10.  Multidetector computed tomography (MDCT) evaluation of myocardial viability: intraindividual comparison of monomeric vs. dimeric contrast media in a rabbit model.

Authors:  Andreas H Mahnken; Gregor Jost; Philipp Bruners; Martin Sieber; Peter R Seidensticker; Rolf W Günther; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-08-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.